Conversion to belatacept after lung transplantation: Report of 10 cases

Conversion to belatacept after lung transplantation: Report of 10 cases

Show other versions (1)

<h4>Background</h4> Calcineurin inhibitors (CNIs) remain the cornerstone of maintenance immunosuppression (IS) after lung transplantation (LTx), although CNI-related life-threatening toxic effects may occur. Belatacept, a novel immunosuppressant that blocks a T-cell co-stimulation pathwa...

Full description

Bibliographic Details
Main Authors: Olivier Brugière, Alexandre Vallée, Quentin Raimbourg, Marie-Noelle Peraldi, Sylvie Colin de Verdière, Laurence Beaumont, Abdulmonem Hamid, Mathilde Zrounba, Antoine Roux, Clément Picard, François Parquin, Matthieu Glorion, Julie Oniszczuk, Alexandre Hertig, Hervé Mal, Vincent Bunel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016650/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016650/?tool=EBI

Similar Items